These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18447935)

  • 1. Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia.
    Morken G; Widen JH; Grawe RW
    BMC Psychiatry; 2008 Apr; 8():32. PubMed ID: 18447935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of integrated treatment on antipsychotic medication adherence in a randomized trial in recent-onset schizophrenia.
    Morken G; Grawe RW; Widen JH
    J Clin Psychiatry; 2007 Apr; 68(4):566-71. PubMed ID: 17474812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence.
    Si T; Li N; Lu H; Cai S; Zhuo J; Correll CU; Zhang L; Feng Y
    J Psychopharmacol; 2018 Jun; 32(6):691-701. PubMed ID: 29764266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
    Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
    Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.
    Perkins DO; Johnson JL; Hamer RM; Zipursky RB; Keefe RS; Centorrhino F; Green AI; Glick IB; Kahn RS; Sharma T; Tohen M; McEvoy JP; Weiden PJ; Lieberman JA;
    Schizophr Res; 2006 Mar; 83(1):53-63. PubMed ID: 16529910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT).
    Priebe S; Burton A; Ashby D; Ashcroft R; Burns T; David A; Eldridge S; Firn M; Knapp M; McCabe R
    BMC Psychiatry; 2009 Sep; 9():61. PubMed ID: 19785727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of involuntary hospitalization on medication adherence, treatment engagement and perception of coercion.
    Jaeger S; Pfiffner C; Weiser P; Längle G; Croissant D; Schepp W; Kilian R; Becker T; Eschweiler G; Steinert T
    Soc Psychiatry Psychiatr Epidemiol; 2013 Nov; 48(11):1787-96. PubMed ID: 23604621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care.
    Ascher-Svanum H; Faries DE; Zhu B; Ernst FR; Swartz MS; Swanson JW
    J Clin Psychiatry; 2006 Mar; 67(3):453-60. PubMed ID: 16649833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socio-demographic, clinical and treatment characteristics of relapsing schizophrenic patients.
    San L; Bernardo M; Gómez A; Martínez P; González B; Peña M
    Nord J Psychiatry; 2013 Feb; 67(1):22-9. PubMed ID: 22429047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.
    Byerly MJ; Fisher R; Carmody T; Rush AJ
    J Clin Psychiatry; 2005 Aug; 66(8):997-1001. PubMed ID: 16086614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is our clinical practice of antipsychotic relapse prevention in schizophrenia really evidence-based].
    Schanda H; Stompe T
    Neuropsychiatr; 2010; 24(1):14-26. PubMed ID: 20146916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
    Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
    Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials.
    Leucht C; Heres S; Kane JM; Kissling W; Davis JM; Leucht S
    Schizophr Res; 2011 Apr; 127(1-3):83-92. PubMed ID: 21257294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.